In millions, except per share items | Jun-30-23 | Jun-05-23 | Mar-31-23 | Mar-05-23 | Dec-31-22 | Dec-05-22 | Sep-30-22 | Sep-05-22 |
| 10-Q | 8-K | 10-Q | 8-K | 10-K | 8-K | 10-Q | 8-K |
Net income | 1.4 | 1.4 | 0.7 | 0.0 | -2.2 | | 2.3 | 2.3 |
Depreciation and amortization | 2.1 | 2.1 | 1.9 | 1.9 | 1.8 | 1.8 | 1.7 | 1.7 |
Asset impairment charges | | | | 0.0 | | 0.2 | | |
Stock-based compensation | 1.7 | 1.3 | 1.8 | 1.4 | 0.2 | 1.4 | 1.7 | 1.3 |
Deferred taxes | | 0.2 | | 0.0 | 0.1 | -0.1 | | 0.0 |
Change in working capital [+] | -0.6 | -1.6 | -1.3 | -2.8 | -1.7 | 3.0 | 0.2 | -2.1 |
Accounts receivable | | -0.8 | | -1.0 | -2.0 | 0.9 | | -2.4 |
Other current assets | | | | -0.5 | -0.2 | -0.2 | | |
Accounts payable | -0.7 | -0.7 | 0.1 | 0.1 | 0.6 | 0.6 | 0.1 | 0.1 |
Accrued expenses | 0.0 | | -1.5 | | 1.3 | | 0.1 | |
Deferred revenues | | | | 0.1 | | -0.2 | | |
Other | | -0.1 | | -1.5 | -1.5 | | | 0.1 |
Other operating activities | -1.0 | 0.2 | -1.6 | 1.1 | 6.0 | | -2.8 | 0.0 |
Cash from operations | 3.5 | 3.5 | 1.5 | 1.5 | 4.4 | 4.4 | 3.1 | 3.1 |
|
Capital expenditures [+] | 2.2 | 0.0 | 2.3 | 0.0 | -15.2 | -0.1 | 2.3 | -0.1 |
Purchases of property and equipment | 0.0 | 0.0 | 0.0 | 0.0 | -0.6 | -0.1 | 0.1 | -0.1 |
Capitalized product costs | 2.2 | | 2.3 | | -14.6 | | 2.2 | |
Other cash from investing | -4.5 | -2.2 | -4.6 | -2.3 | 12.8 | | -4.6 | -2.2 |
Cash from investing | -2.2 | -2.2 | -2.3 | -2.3 | -2.4 | -2.4 | -2.3 | -2.3 |
|
Issuance of common stock, net | 0.7 | 0.2 | 0.2 | -0.1 | 4.8 | 5.2 | 0.4 | 1.5 |
Other cash from financing | -1.5 | -0.9 | -0.4 | -0.1 | -6.2 | -6.6 | -2.3 | -3.4 |
Cash from financing | -0.8 | -0.8 | -0.2 | -0.2 | -1.4 | -1.4 | -1.9 | -1.9 |
|
Free cash flow | 3.6 | 3.5 | 1.6 | 1.5 | 3.7 | 4.3 | 3.2 | 3.1 |
Per share (diluted) | $0.41 | $0.25 | $0.27 | $0.00 | ($0.77) | | $0.40 | $0.23 |
|
Cash paid for income taxes | 0.0 | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |